Africa’s Health Systems Under Intense Pressure as COVID-19 Deaths Increase by 43% in One Week 15/07/2021 Paul Adepoju Africa experienced a 43% week-on-week increase in COVID-19 deaths, as the Delta variant accelerated infections for the eighth week in a row, the World Health Organisation (WHO) reported at its weekly Africa press briefing. Hospital admissions increase rapidly and countries face shortages in oxygen and intensive care beds, as the Africa hit six million cumulative […] Continue reading -> COVID-19 Vaccine Rollout Halted in Parts of South Africa Due to Civil Unrest 13/07/2021 Chandre Prince JOHANNESBURG – Violent unrest in South Africa has had a disastrous impact on the country’s healthcare and emergency services and has brought the COVID-19 vaccine roll-out to a near standstill in at least two provinces, as the country continues to battle with a third wave of the pandemic. On Tuesday, the national health department temporarily […] Continue reading -> Vaccine Booster Shot Row Continues as Pfizer Trial Nears Conclusion 13/07/2021 Kerry Cullinan Pharmaceutical companies continue to develop COVID-19 vaccine boosters amid condemnation of people in wealthy countries getting additional shots when much of the world is unvaccinated. The US Health and Human Services Department reiterated on Monday that booster shots were not necessary for fully vaccinated Americans after meeting with Pfizer, which is conducting a booster trial. […] Continue reading -> Leading COVID Vaccines Linked to Rare Side Effects 13/07/2021 Madeleine Hoecklin The single-dose Johnson & Johnson COVID-19 vaccine could lead to an increased risk of a rare neurological condition, warned the US Food and Drug Administration (FDA) on Monday, adding it to the list of possible side effects. This comes along with a series of new reports on the side effects associated with the leading COVID-19 […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> As Africa Experiences ‘Worst Pandemic Week’, COVAX Promises Accelerated Delivery of Vaccines from September 08/07/2021 Paul Adepoju As Africa recorded its worst pandemic week, the COVAX Facility announced on Thursday that it has taken steps to quickly resume the delivery of vaccines to African countries including diversifying its portfolio of COVID-19 vaccines. Aurélia Nguyen, Managing Director of the COVAX Facility based at Gavi, the Vaccine Alliance, said the COVAX portfolio now consists […] Continue reading -> New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> COVID Pandemic in a Dangerous and Fragile Phase, as Surges are Reported Globally 06/07/2021 Madeleine Hoecklin As many high-income countries are relaxing restrictions for the summer months, low- and middle-income countries (LMICs) are witnessing rises in cases, deaths, and overwhelmed hospitals. Countries in Europe and the United States are increasingly allowing in travellers, ending mask mandates, and allowing large gatherings including football matches and concerts. At the same time, the third […] Continue reading -> Russia Pushes Ahead with Open License Approach to Sputnik V – Despite WHO Concerns Over Manufacturing Practices 02/07/2021 Svĕt Lustig Vijay Despite the emergence of new WHO concerns over quality control at Sputnik V’s domestic production facilities, the Russian Direct Investment Fund (RDIF) is pushing ahead with a massive international “open-license” manufacturing effort for its Sputnik V vaccine – which breaks the traditional model of vaccine production and leverages existing capacity in poorer countries, desperate for […] Continue reading -> WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 Vaccine Rollout Halted in Parts of South Africa Due to Civil Unrest 13/07/2021 Chandre Prince JOHANNESBURG – Violent unrest in South Africa has had a disastrous impact on the country’s healthcare and emergency services and has brought the COVID-19 vaccine roll-out to a near standstill in at least two provinces, as the country continues to battle with a third wave of the pandemic. On Tuesday, the national health department temporarily […] Continue reading -> Vaccine Booster Shot Row Continues as Pfizer Trial Nears Conclusion 13/07/2021 Kerry Cullinan Pharmaceutical companies continue to develop COVID-19 vaccine boosters amid condemnation of people in wealthy countries getting additional shots when much of the world is unvaccinated. The US Health and Human Services Department reiterated on Monday that booster shots were not necessary for fully vaccinated Americans after meeting with Pfizer, which is conducting a booster trial. […] Continue reading -> Leading COVID Vaccines Linked to Rare Side Effects 13/07/2021 Madeleine Hoecklin The single-dose Johnson & Johnson COVID-19 vaccine could lead to an increased risk of a rare neurological condition, warned the US Food and Drug Administration (FDA) on Monday, adding it to the list of possible side effects. This comes along with a series of new reports on the side effects associated with the leading COVID-19 […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> As Africa Experiences ‘Worst Pandemic Week’, COVAX Promises Accelerated Delivery of Vaccines from September 08/07/2021 Paul Adepoju As Africa recorded its worst pandemic week, the COVAX Facility announced on Thursday that it has taken steps to quickly resume the delivery of vaccines to African countries including diversifying its portfolio of COVID-19 vaccines. Aurélia Nguyen, Managing Director of the COVAX Facility based at Gavi, the Vaccine Alliance, said the COVAX portfolio now consists […] Continue reading -> New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> COVID Pandemic in a Dangerous and Fragile Phase, as Surges are Reported Globally 06/07/2021 Madeleine Hoecklin As many high-income countries are relaxing restrictions for the summer months, low- and middle-income countries (LMICs) are witnessing rises in cases, deaths, and overwhelmed hospitals. Countries in Europe and the United States are increasingly allowing in travellers, ending mask mandates, and allowing large gatherings including football matches and concerts. At the same time, the third […] Continue reading -> Russia Pushes Ahead with Open License Approach to Sputnik V – Despite WHO Concerns Over Manufacturing Practices 02/07/2021 Svĕt Lustig Vijay Despite the emergence of new WHO concerns over quality control at Sputnik V’s domestic production facilities, the Russian Direct Investment Fund (RDIF) is pushing ahead with a massive international “open-license” manufacturing effort for its Sputnik V vaccine – which breaks the traditional model of vaccine production and leverages existing capacity in poorer countries, desperate for […] Continue reading -> WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> Posts navigation Older postsNewer posts
Vaccine Booster Shot Row Continues as Pfizer Trial Nears Conclusion 13/07/2021 Kerry Cullinan Pharmaceutical companies continue to develop COVID-19 vaccine boosters amid condemnation of people in wealthy countries getting additional shots when much of the world is unvaccinated. The US Health and Human Services Department reiterated on Monday that booster shots were not necessary for fully vaccinated Americans after meeting with Pfizer, which is conducting a booster trial. […] Continue reading -> Leading COVID Vaccines Linked to Rare Side Effects 13/07/2021 Madeleine Hoecklin The single-dose Johnson & Johnson COVID-19 vaccine could lead to an increased risk of a rare neurological condition, warned the US Food and Drug Administration (FDA) on Monday, adding it to the list of possible side effects. This comes along with a series of new reports on the side effects associated with the leading COVID-19 […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> As Africa Experiences ‘Worst Pandemic Week’, COVAX Promises Accelerated Delivery of Vaccines from September 08/07/2021 Paul Adepoju As Africa recorded its worst pandemic week, the COVAX Facility announced on Thursday that it has taken steps to quickly resume the delivery of vaccines to African countries including diversifying its portfolio of COVID-19 vaccines. Aurélia Nguyen, Managing Director of the COVAX Facility based at Gavi, the Vaccine Alliance, said the COVAX portfolio now consists […] Continue reading -> New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> COVID Pandemic in a Dangerous and Fragile Phase, as Surges are Reported Globally 06/07/2021 Madeleine Hoecklin As many high-income countries are relaxing restrictions for the summer months, low- and middle-income countries (LMICs) are witnessing rises in cases, deaths, and overwhelmed hospitals. Countries in Europe and the United States are increasingly allowing in travellers, ending mask mandates, and allowing large gatherings including football matches and concerts. At the same time, the third […] Continue reading -> Russia Pushes Ahead with Open License Approach to Sputnik V – Despite WHO Concerns Over Manufacturing Practices 02/07/2021 Svĕt Lustig Vijay Despite the emergence of new WHO concerns over quality control at Sputnik V’s domestic production facilities, the Russian Direct Investment Fund (RDIF) is pushing ahead with a massive international “open-license” manufacturing effort for its Sputnik V vaccine – which breaks the traditional model of vaccine production and leverages existing capacity in poorer countries, desperate for […] Continue reading -> WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> Posts navigation Older postsNewer posts
Leading COVID Vaccines Linked to Rare Side Effects 13/07/2021 Madeleine Hoecklin The single-dose Johnson & Johnson COVID-19 vaccine could lead to an increased risk of a rare neurological condition, warned the US Food and Drug Administration (FDA) on Monday, adding it to the list of possible side effects. This comes along with a series of new reports on the side effects associated with the leading COVID-19 […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> As Africa Experiences ‘Worst Pandemic Week’, COVAX Promises Accelerated Delivery of Vaccines from September 08/07/2021 Paul Adepoju As Africa recorded its worst pandemic week, the COVAX Facility announced on Thursday that it has taken steps to quickly resume the delivery of vaccines to African countries including diversifying its portfolio of COVID-19 vaccines. Aurélia Nguyen, Managing Director of the COVAX Facility based at Gavi, the Vaccine Alliance, said the COVAX portfolio now consists […] Continue reading -> New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> COVID Pandemic in a Dangerous and Fragile Phase, as Surges are Reported Globally 06/07/2021 Madeleine Hoecklin As many high-income countries are relaxing restrictions for the summer months, low- and middle-income countries (LMICs) are witnessing rises in cases, deaths, and overwhelmed hospitals. Countries in Europe and the United States are increasingly allowing in travellers, ending mask mandates, and allowing large gatherings including football matches and concerts. At the same time, the third […] Continue reading -> Russia Pushes Ahead with Open License Approach to Sputnik V – Despite WHO Concerns Over Manufacturing Practices 02/07/2021 Svĕt Lustig Vijay Despite the emergence of new WHO concerns over quality control at Sputnik V’s domestic production facilities, the Russian Direct Investment Fund (RDIF) is pushing ahead with a massive international “open-license” manufacturing effort for its Sputnik V vaccine – which breaks the traditional model of vaccine production and leverages existing capacity in poorer countries, desperate for […] Continue reading -> WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> Posts navigation Older postsNewer posts
15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> As Africa Experiences ‘Worst Pandemic Week’, COVAX Promises Accelerated Delivery of Vaccines from September 08/07/2021 Paul Adepoju As Africa recorded its worst pandemic week, the COVAX Facility announced on Thursday that it has taken steps to quickly resume the delivery of vaccines to African countries including diversifying its portfolio of COVID-19 vaccines. Aurélia Nguyen, Managing Director of the COVAX Facility based at Gavi, the Vaccine Alliance, said the COVAX portfolio now consists […] Continue reading -> New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> COVID Pandemic in a Dangerous and Fragile Phase, as Surges are Reported Globally 06/07/2021 Madeleine Hoecklin As many high-income countries are relaxing restrictions for the summer months, low- and middle-income countries (LMICs) are witnessing rises in cases, deaths, and overwhelmed hospitals. Countries in Europe and the United States are increasingly allowing in travellers, ending mask mandates, and allowing large gatherings including football matches and concerts. At the same time, the third […] Continue reading -> Russia Pushes Ahead with Open License Approach to Sputnik V – Despite WHO Concerns Over Manufacturing Practices 02/07/2021 Svĕt Lustig Vijay Despite the emergence of new WHO concerns over quality control at Sputnik V’s domestic production facilities, the Russian Direct Investment Fund (RDIF) is pushing ahead with a massive international “open-license” manufacturing effort for its Sputnik V vaccine – which breaks the traditional model of vaccine production and leverages existing capacity in poorer countries, desperate for […] Continue reading -> WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> Posts navigation Older postsNewer posts
As Africa Experiences ‘Worst Pandemic Week’, COVAX Promises Accelerated Delivery of Vaccines from September 08/07/2021 Paul Adepoju As Africa recorded its worst pandemic week, the COVAX Facility announced on Thursday that it has taken steps to quickly resume the delivery of vaccines to African countries including diversifying its portfolio of COVID-19 vaccines. Aurélia Nguyen, Managing Director of the COVAX Facility based at Gavi, the Vaccine Alliance, said the COVAX portfolio now consists […] Continue reading -> New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> COVID Pandemic in a Dangerous and Fragile Phase, as Surges are Reported Globally 06/07/2021 Madeleine Hoecklin As many high-income countries are relaxing restrictions for the summer months, low- and middle-income countries (LMICs) are witnessing rises in cases, deaths, and overwhelmed hospitals. Countries in Europe and the United States are increasingly allowing in travellers, ending mask mandates, and allowing large gatherings including football matches and concerts. At the same time, the third […] Continue reading -> Russia Pushes Ahead with Open License Approach to Sputnik V – Despite WHO Concerns Over Manufacturing Practices 02/07/2021 Svĕt Lustig Vijay Despite the emergence of new WHO concerns over quality control at Sputnik V’s domestic production facilities, the Russian Direct Investment Fund (RDIF) is pushing ahead with a massive international “open-license” manufacturing effort for its Sputnik V vaccine – which breaks the traditional model of vaccine production and leverages existing capacity in poorer countries, desperate for […] Continue reading -> WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> Posts navigation Older postsNewer posts
New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> COVID Pandemic in a Dangerous and Fragile Phase, as Surges are Reported Globally 06/07/2021 Madeleine Hoecklin As many high-income countries are relaxing restrictions for the summer months, low- and middle-income countries (LMICs) are witnessing rises in cases, deaths, and overwhelmed hospitals. Countries in Europe and the United States are increasingly allowing in travellers, ending mask mandates, and allowing large gatherings including football matches and concerts. At the same time, the third […] Continue reading -> Russia Pushes Ahead with Open License Approach to Sputnik V – Despite WHO Concerns Over Manufacturing Practices 02/07/2021 Svĕt Lustig Vijay Despite the emergence of new WHO concerns over quality control at Sputnik V’s domestic production facilities, the Russian Direct Investment Fund (RDIF) is pushing ahead with a massive international “open-license” manufacturing effort for its Sputnik V vaccine – which breaks the traditional model of vaccine production and leverages existing capacity in poorer countries, desperate for […] Continue reading -> WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> Posts navigation Older postsNewer posts
COVID Pandemic in a Dangerous and Fragile Phase, as Surges are Reported Globally 06/07/2021 Madeleine Hoecklin As many high-income countries are relaxing restrictions for the summer months, low- and middle-income countries (LMICs) are witnessing rises in cases, deaths, and overwhelmed hospitals. Countries in Europe and the United States are increasingly allowing in travellers, ending mask mandates, and allowing large gatherings including football matches and concerts. At the same time, the third […] Continue reading -> Russia Pushes Ahead with Open License Approach to Sputnik V – Despite WHO Concerns Over Manufacturing Practices 02/07/2021 Svĕt Lustig Vijay Despite the emergence of new WHO concerns over quality control at Sputnik V’s domestic production facilities, the Russian Direct Investment Fund (RDIF) is pushing ahead with a massive international “open-license” manufacturing effort for its Sputnik V vaccine – which breaks the traditional model of vaccine production and leverages existing capacity in poorer countries, desperate for […] Continue reading -> WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> Posts navigation Older postsNewer posts
Russia Pushes Ahead with Open License Approach to Sputnik V – Despite WHO Concerns Over Manufacturing Practices 02/07/2021 Svĕt Lustig Vijay Despite the emergence of new WHO concerns over quality control at Sputnik V’s domestic production facilities, the Russian Direct Investment Fund (RDIF) is pushing ahead with a massive international “open-license” manufacturing effort for its Sputnik V vaccine – which breaks the traditional model of vaccine production and leverages existing capacity in poorer countries, desperate for […] Continue reading -> WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> Posts navigation Older postsNewer posts
WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> Posts navigation Older postsNewer posts